Compare MGPI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGPI | OABI |
|---|---|---|
| Founded | 1941 | 2012 |
| Country | United States | United States |
| Employees | 267 | 89 |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.9M | 391.4M |
| IPO Year | 1994 | N/A |
| Metric | MGPI | OABI |
|---|---|---|
| Price | $16.63 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $28.75 | $4.50 |
| AVG Volume (30 Days) | 226.0K | ★ 562.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.50% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,782,000.00 | N/A |
| Revenue This Year | N/A | $52.42 |
| Revenue Next Year | $5.11 | $64.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.72 | $1.32 |
| 52 Week High | $32.60 | $2.79 |
| Indicator | MGPI | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 49.88 |
| Support Level | $16.09 | $1.75 |
| Resistance Level | $18.95 | $2.70 |
| Average True Range (ATR) | 0.78 | 0.19 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 41.15 | 54.91 |
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.